Parvin Asset Management LLC bought a new stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 6,735 shares of the company’s stock, valued at approximately $988,000.
Several other institutional investors also recently modified their holdings of the business. Proficio Capital Partners LLC purchased a new position in Procter & Gamble during the 2nd quarter valued at about $1,561,000. Stonebridge Capital Management Inc. purchased a new stake in Procter & Gamble in the second quarter worth about $2,774,000. Pure Financial Advisors LLC bought a new position in shares of Procter & Gamble during the second quarter valued at approximately $2,804,000. Transamerica Financial Advisors LLC bought a new position in shares of Procter & Gamble during the second quarter valued at approximately $1,582,000. Finally, Corient Private Wealth LP purchased a new position in shares of Procter & Gamble during the second quarter valued at approximately $335,908,000. 65.77% of the stock is currently owned by institutional investors.
Insider Transactions at Procter & Gamble
In related news, CAO Matthew W. Janzaruk sold 359 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total value of $52,141.16. Following the sale, the chief accounting officer owned 1,271 shares in the company, valued at approximately $184,600.04. This trade represents a 22.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 2,238 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $321,802.02. Following the completion of the sale, the insider directly owned 26,989 shares of the company’s stock, valued at approximately $3,880,748.31. This trade represents a 7.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 6,627 shares of company stock worth $953,417 over the last three months. 0.20% of the stock is currently owned by company insiders.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same quarter in the previous year, the business earned $1.48 earnings per share. The company’s revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, August 17th. Stockholders of record on Friday, July 24th were issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.
Analysts Set New Price Targets
Several research firms recently weighed in on PG. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research note on Thursday, July 16th. Citigroup dropped their target price on Procter & Gamble from $181.00 to $170.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Barclays increased their target price on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Procter & Gamble in a research report on Wednesday, August 19th. Finally, Bank of America dropped their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research note on Friday, July 10th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $161.19.
Check Out Our Latest Research Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
- Five stocks we like better than Procter & Gamble
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
